Baseline characteristics of the study participants.

<p>Data are presented as means ± standard deviation or percentages. p-value, unpaired t-test or chi-square test (normoalbuminuria group vs. Moderately increased albuminuria group). BP, blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HbA1c, glycated hemoglobin; NGSP, National Glycohemoglobin Standardization Program; eGFR, estimated glomerular filtration ratio; UACR, urine albumin-to-creatinine ratio.</p><p>Baseline characteristics of the study participants.</p

Kaplan–Meier curves for cumulative incidence of major cardiovascular events in normoalbuminuria and microalbuminuria groups.

<p>Kaplan–Meier curves for cumulative incidence of major cardiovascular events in normoalbuminuria and microalbuminuria groups.</p

Results of the univariate Cox proportional hazard analysis for major cardiovascular events.

<p>Abbreviations as shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0123893#pone.0123893.t001" target="_blank">Table 1</a>.</p><p>Results of the univariate Cox proportional hazard analysis for major cardiovascular events.</p

Flow chart of the selection of study participants.

<p>Flow chart of the selection of study participants.</p

Total, differential cell and lymphocyte profiles in the BALF of control and MAC patients.

<p>Cell pellets were counted in a hemocytometer, and Diff-Quik^™ (International Reagents, Kobe, Japan)-stained smears were used to identify the differential profiles after cytospin preparation. Differential counts were performed by examining 300 cells using a standard light microscope. Data are represented as means ± SEM. *P < 0.05 ** P < 0.01 †P < 0.001. Mϕ = Macrophage, Neu = Neutrophil, Ly = Lymphocyte. LD: lymphocyte-dominant. ND: neutrophil-dominant. MAC: <i>Mycobacterium avium</i> complex.</p

Local immunological status and disease progression after bronchoalveolar lavage in subjects who were followed-up without treatment.

<p>Local immunological status and disease progression after bronchoalveolar lavage in subjects who were followed-up without treatment.</p

Subject characteristics.

<p>Subject characteristics.</p

HRCT scores of lavaged pulmonary segments.

<p>HRCT scores of lavaged pulmonary segments.</p

HRCT scores of the lavaged pulmonary segment at baseline who were followed-up without treatment after the bronchoalveolar lavage.

<p>HRCT scores of the lavaged pulmonary segment at baseline who were followed-up without treatment after the bronchoalveolar lavage.</p

Summary of the HRCT scoring system of the lavaged lung.

<p>Summary of the HRCT scoring system of the lavaged lung.</p